Ensuring Future Protection Strategies thumbnail

Ensuring Future Protection Strategies

Published Oct 08, 26
2 min read


Medicare Benefit Plans readily available nationwide in 2026. The number of plans readily available to an individual Medicare recipient differs from state to state.

The typical month-to-month premium for Medicare Advantage plans with prescription drug coverage is expected to decrease from $16 in 2025 to $14 in 2026. It is approximated that about 81% of Medicare recipients are enrolled in Part D, which covers prescription drug expenditures. The CMS approximates that month-to-month premiums for stand-alone Part D strategies will drop from $38 in 2025 to $34 in 2026.

Insurance in Moorpark CA
Harmony SoCal InsuranceHarmony SoCal Insurance


Insurance companies will be allowed to raise Part D premiums as much as $50 monthly, higher than the present $35 month-to-month optimum. Medicare authorities are anticipated to continue to negotiate rates for drugs covered under Part D.Experts state that could result in discounts of 38% to 79% on sale price on 10 widely used prescriptions, including blood slimmers Eliquis and Xarelto, as well as diabetes medications Januvia, Jardiance, and Farxiga. People with Part D plans will also continue to have the option to utilize an automatic prescription payment plan that expands drug costs for many years.

In the end, it indicates less money in customers' pockets." Kanwar Kelley, MD, a specialist in otolaryngology head and neck surgery, weight problems medicine, and lifestyle medicine as well as the co-founder and president of Side Health in Orinda, CA.Despite these rate reductions, professionals state some Medicare receivers could still pay more for prescription drugs."Although the price of Part D (drug benefits) might reduce overall, the reduction in choices and changes to covered medications could lead to higher costs for customers of specific specialized medications," Kelley noted.

Share us on...

Latest Posts

How Whole Life Works

Published Oct 25, 26
5 min read